A test to gauge recurrence risk for kidney cancer is unable to predict which patients will benefit from adjuvant therapy
An American company called Genomic Health has been collaborating with [...]
Potential molecular scoring method for predicting survival in metastatic kidney cancer
A recent study presented at the American Urology Association (AUA) [...]
